Insmed’s iPlex Gets Updated User Fee Date Of Dec. 12
This article was originally published in The Pink Sheet Daily
Executive Summary
Insmed's NDA for the growth therapy iPlex (mecasermin rinfibate) has an updated user fee date of Dec. 12, the firm announced Oct. 25